Diabetes

One in 11 Americans has diabetes today, and 86 million more – about one in three – are at risk for developing type 2 diabetes.

The 77th Annual Scientific Sessions of the American Diabetes Association is being held in San Diego June 9 through June 13

The 77th Annual Scientific Sessions of the American Diabetes Association is being held in San Diego this weekend, June 9 through June 13, and Pharmacy Times will bring you all the latest diabetes news from this meeting.

Most experts recommend adding basal insulin, but basalization has its limits controlling glucose in type 2 diabetes.

Patients who were seen at an emergency department had an increased likelihood of diabetic ketoacidosis during the next 14 days.

There are no guidelines to help physicians choose insole stiffness for patients with diabetes.

Top news of the day from across the health care landscape.

Drug interactions can affect the pharmacokinetics or pharmacodynamics of diabetes medications, causing decreased efficacy or increased toxicity.

Teenagers face cognitive, social, and psychological pressures that can interfere with successful diabetes management.

The creation of novel investigational drugs that target a protein receptor found in fat tissue could pave the way for better treatments for type 2 diabetes.

Active ingredients in chili peppers and cannabis help subside gut inflammation, and could lead to new therapies for diabetes and colitis.

Metformin may treat Fragile X syndrome.

Vitamin A and a high-fat diet could lead to a high body mass index.

As the prevalence of diabetes continues to rise, the development of safer and more efficient therapeutics is increasing in importance.

Targeting a protein receptor in body fat shows promise in attacking diabetes.

Children with obesity may be 4 times more likely to develop type 2 diabetes.

Cardiovascular disease among diabetes patients drops through coordinated healthcare.

FDA issues safety warning for canagliflozin in the treatment of type 2 diabetes.

Canagliflozin (Invokana) may increase the risk of leg and foot amputations in patients with type 2 diabetes.

Top news of the day from across the health care landscape.

Pharmacists can help patients with diabetes manage glucose control.

Adherence to diabetes therapy related to the high cost of treatment.

Research demonstrates that pharmacists can make a difference for patients with diabetes.

Postbiotics observed to reduce blood glucose levels and increase insulin sensitivity in patients with diabetes.

Nonadherence in patients with diabetes adversely affects glycemic control.